Investigator Grant Payments

INVESTIGATOR GRANT PAYMENTS WHITE PAPERS AND CASE STUDIES

INVESTIGATOR GRANT PAYMENTS PRODUCTS & SERVICES

Access the future of AI microscopy

Subjectivity of analysis and poor reproducibility are key hurdles to be overcome for biological image analysis. Standard segmentation can lead to sub-standard results and require substantial manual curation which is subject to human error.

Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.

Ensuring Safe Handling of High-Risk Biological Agents

Gloveboxes serve the needs of a diverse range of industries including biotechnology, biomedical, nuclear, defense, pharmaceutical, semiconductor and chemical applications. When these enclosures are used for microbiological research or to handle pathogens, they are referred to as Class III Biosafety Cabinets.

A.H. Systems' Preamplifier line is an excellent choice with a rugged design, no hassles with soldering your own power leads and they improve overall system sensitivity by at least 20 dB. 

To meet the multitude of demands across various industries, such as drug manufacturing and their applications, Arcoplast developed four different kinds of GFRP panel.

120Water’s PWS Portal allows utilities to build the data foundation to power efficient water quality program management.

The PuroVaso® pharmaceutical container has been meticulously developed using our experience of powder handling and our knowledge of the challenges facing small handling solutions.

Leveraging expertise in formulation development and advanced technical capabilities can help accelerate your drug product to market with ease.

INVESTIGATOR GRANT PAYMENTS NEWS

ABOUT

Investigator Grant Payments
In the clinical trials industry, there is usually the pressure of making profits while maintaining regulatory compliance. In order to maximize on their research and development spending, pharmaceutical companies are reducing clinical trial cycle times.
However, there are an increasing number of clinical trials, with more complex protocols and more stringent regulatory requirements. Despite all these, many sponsors issue late payments to investigative sites, and many of these sites are struggling to maintain financial viability.
If the sponsors want to maintain strong, effective investigative sites, they need to build strong relationships with them. This involves coming up with a more effective approach to investigator grant payments. This will not only improve investigator relationships and satisfaction, it will help sponsors to accelerate cycle times and reduce the costs of clinical trials.
First, there is a need to understand that accounts payable in the clinical trials industry are very complex. Investigator grant payments are driven by the terms of the clinical trial agreement. These agreements are highly complex documents with various variables that can impact on the grant payment.
There is also a need for better management of investigator grant payments through the right personnel. Apart from having a background in finance and accounting, those in charge ought to have some experience in financial management of clinical trials.
Such a person would understand the standard process for a clinical trial, from screening to treatment of patients. He or she should be able to read and understand how the clinical study is progressing against the clinical trial agreement.